Praxbind and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Praxbind (idarucizumab), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Pradaxa, and have Thrombolysis.

The phase IV clinical study analyzes which people have Stroke when taking Praxbind. It is created by eHealthMe based on reports of 1,391 people who have side effects when taking Praxbind from the FDA, and is updated regularly.

What is Praxbind?

Praxbind has active ingredients of idarucizumab. eHealthMe is studying from 1,391 Praxbind users. Check the latest studies of Praxbind.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,337 drugs and 3,028 conditions by eHealthMe. Check the latest studies of Stroke.

On Jun, 20, 2026

1,391 people reported to have side effects when taking Praxbind.
Among them, 28 people (2.01%) have Stroke.

Among these 28 people:

How long have people been on Praxbind when they have Stroke? *

What is the gender of people who have Stroke when taking Praxbind? *

female: 34.62 %
male: 65.38 %

What is the age of people who have Stroke when taking Praxbind? *

What are other drugs people take besides Praxbind? *

Pradaxa: 4 people, 14.29%
Fragmin: 1 person, 3.57%

What are other side effects people have besides Stroke? *

Cerebral Haemorrhage (bleeding within the brain): 3 people, 10.71%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 3 people, 10.71%
Thrombin Time Prolonged: 2 people, 7.14%
Speech Impairment (Adult) (inability to speak (adult)): 2 people, 7.14%
Speech Disorder: 2 people, 7.14%
Coagulation Time Shortened: 2 people, 7.14%
Haematemesis (vomiting of blood): 2 people, 7.14%
Haemorrhagic Anaemia (anaemia due to excessive bleeding): 1 person, 3.57%
Bedridden: 1 person, 3.57%
Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 1 person, 3.57%

What are the existing conditions these people have? *

Thrombolysis (resolving the blood clot): 4 people, 14.29%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 10.71%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 2 people, 7.14%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 1 person, 3.57%
Ischaemic Stroke (stroke; caused by an interruption in the flow of blood to the brain): 1 person, 3.57%
Haemorrhage (bleeding): 1 person, 3.57%
Femur Fracture: 1 person, 3.57%
Cerebral Ischaemia (insufficient blood flow to the brain to meet metabolic demand): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Praxbind and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Praxbind:

Praxbind (1,391 reports)

Stroke treatments and more:

Stroke (334,635 reports)

Browse all side effects of Praxbind:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,337 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,028 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on idarucizumab (the active ingredients of Praxbind) and Praxbind (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.